[{"@context":"https:\/\/schema.org\/","@type":"BlogPosting","@id":"https:\/\/www.brppharma.com\/gabapentin-classified-as-a-schedule-v-drug#BlogPosting","mainEntityOfPage":"https:\/\/www.brppharma.com\/gabapentin-classified-as-a-schedule-v-drug","headline":"Gabapentin Classified as a Schedule V Drug","name":"Gabapentin Classified as a Schedule V Drug","description":"Recent changes to Virginia\u2019s Controlled Substance Rules and Regulations have changed. Effective July 1, 2019: Bill Summary \u2022 Updates Schedule V to classify gabapentin as a Schedule V controlled substance. \u2022 Removes gabapentin as a drug of concern. \u2022 Requires wholesale distributors to maintain proper storage for Schedule V controlled substances containing gabapentin. Please visit […]","datePublished":"2019-07-14","dateModified":"2022-06-29","author":{"@type":"Person","@id":"https:\/\/www.brppharma.com\/author\/brppharma#Person","name":"BRP Pharmaceuticals","url":"https:\/\/www.brppharma.com\/author\/brppharma","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/1823a51a9ebb71b301035ef253ad87e9ea23d88aadbe3f3c420e18ff5966659f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1823a51a9ebb71b301035ef253ad87e9ea23d88aadbe3f3c420e18ff5966659f?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"BRP Pharmaceuticals","logo":{"@type":"ImageObject","@id":"https:\/\/www.brppharma.com\/wp-content\/uploads\/2017\/10\/brp-logo.png","url":"https:\/\/www.brppharma.com\/wp-content\/uploads\/2017\/10\/brp-logo.png","width":340,"height":100}},"image":{"@type":"ImageObject","@id":"https:\/\/www.brppharma.com\/wp-content\/uploads\/2018\/08\/brp-Landing-logo.png","url":"https:\/\/www.brppharma.com\/wp-content\/uploads\/2018\/08\/brp-Landing-logo.png","width":133,"height":55},"url":"https:\/\/www.brppharma.com\/gabapentin-classified-as-a-schedule-v-drug","about":["News"],"wordCount":66,"articleBody":"Recent changes to Virginia\u2019s Controlled Substance Rules and Regulations have changed. Effective July 1, 2019:Bill Summary\u2022 Updates Schedule V to classify gabapentin as a Schedule V controlled substance.\u2022 Removes gabapentin as a drug of concern.\u2022 Requires wholesale distributors to maintain proper storage for Schedule V controlled substances containing gabapentin.Please visit the following link for official documentation: https:\/\/www.dhp.virginia.gov\/pharmacy\/docs\/Gabapentin06172019.pdf"},{"@context":"https:\/\/schema.org\/","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Gabapentin Classified as a Schedule V Drug","item":"https:\/\/www.brppharma.com\/gabapentin-classified-as-a-schedule-v-drug#breadcrumbitem"}]}]